| 101/344 | US=15 / Biol/Mol Sugahara KN. Hyaluronan fragments: informational polymers commandeered by cancers. In: Stern R. Hyaluronan in cancer biology. Amsterdam: Elsevier, 2009. p. 221-54. ISBN 978-0-12-374178-3. CANCER; ACIDO HIALURONICO; CD44; RECEPTOR DE MOTILIDADE MEDIADO POR ACIDO HIALURONICO (RHAMM); RECEPTOR TOLL-LIKE (TLR); ANGIOGENESE |
| 102/344 | US=15 / Biol/Mol Miller AD. Hyaluronidase-2 and its role as a cell-entry receptor for sheep retroviruses that cause contagious respiratory tract cancers. In: Stern R. Hyaluronan in cancer biology. Amsterdam: Elsevier, 2009. p. 407-18. ISBN 978-0-12-374178-3. HIALURONIDASE-2; RETROVIRUS; CANCER; TRATO RESPIRATORIO; RETROVIRUS JAAGSIEKTE DE OVINOS; ATIVIDADE ENZIMATICA; ONCOGENESE |
| 103/344 | US=16 / Estatística Xu XC. Risk factors and gene expression in esophageal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 335-60. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE ESOFAGO; FATORES DE RISCO; EXPRESSAO GENICA; TABAGISMO; ALCOOLISMO; REFLUXO GASTROESOFAGICO; ALTERACOES GENETICAS; CANCER. PREVENCAO; ESOFAGO DE BARRET; ADENOCARCINOMA ESOFAGICO; MUTACAO DO GENE P53; ALTERACAO DO GENE P16; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMAL (EGFR); CADERINA-E; COX-2; QUIMIOPREVENCAO; ACIDOS RETINOICOS; ANTI-INFLAMATORIOS NAO ESTEROIDES; EGCG; CURCUMINA |
| 104/344 | US=9 / Quimioterapia Shin S, Kensler TW. Dietary factors regulate metabolism of carcinogens throughtranscriptional signaling pathways. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 109-20. ISBN 978-3-527-32058-5. FATORES DIETETICOS; METABOLISMO DE CARCINOGENOS; VIAS DE SINALIZACAO TRANSCRICIONAIS; NRF2; FATOR NUCLEAR ERITROIDE 2; NRF2-KEAP1; FOSFORILACAO; RECEPTOR DE HIDROCARBONETO AROMATICO; RECEPTORES NUCLEARES |
| 105/344 | US=6 / Quimioterapia Airley R. Tyrosine kinase inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 217-23. ISBN 978-0-470-09254-5. INIBIDORES DA QUINASE DE TIROSINA; NAO-RECEPTOR INIBIDORES DE TIROSINA |
| 106/344 | US=27-A / Clin/Médica Kastner DL. Doenças autoinflamatórias sistêmicas. In: Goldman L, Ausiello D, editors. Cecil medicina. 23ªed. Rio de Janeiro: Elsevier, 2009. p. 2287-93. ISBN 85-3522660-7. DOENCAS AUTOINFLAMATORIAS SISTEMICAS; SINDROME DE FEBRE PERIODICA HEPERATIVA; SINDROME PERIODICA AO RECEPTOR DO FATOR NECROSE TUMORAL; SINDROME DE HIPERIMUNOGLOBULINEMIA D; FEBRE PERIODICA; DOENCAS AUTOINFLAMATORIAS SISTEMICA HEREDITARIA |
| 107/344 | US=8 / Laboratório Dorshkind K, Rawlings DJ. B-cell development. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 105-16. ISBN 978-0-443-06715-0. DESENVOLVIMENTO DAS CELULAS B; HIERARQUIA HEMATOPOIETICA; GENES DE IMUNOGLOBULINAS NA CADEIA PESADA; RECEPTOR DE CELULAS B; REARRANJO DOS GENES DAS CADEIAS LEVE; INTERACOES CELULA-CELULA; CITOCINAS; FATORES SISTEMICOS; CELULAS FETAIS; CELULAS B1; LINFOIDES SECUNDARIOS; ENVELHECIMENTO DAS CELULAS B |
| 108/344 | US=8 / Laboratório Monroe JG, Lenardo MJ. Regulation of activation of B and T lymphocytes. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 144-60. ISBN 978-0-443-06715-0. REGULACAO DA ATIVACAO DE LINFOCITOS; CELULAS B; CELULAS T; RECEPTOR DO ANTIGENO DE LINFOCITO B; SINALIZACAO INTRACELULAR; LINFOCITOS T; RECEPTOR DE ANTIGENO DE CELULAS T; SINALIZACAO INTRACELULAR; MOLECULAS CO-RECEPTORAS; ATIVACAO DAS CELULAS T |
| 109/344 | US=35 / Gastro Kiguchi K, DiGiovanni J. Role of growth factor-signaling pathways. In: Thomas CR Junior, Fuller CD. Biliary tract and gallbladder cancer: diagnosis and therapy. New Jersey: DemosMedical, 2009. p. 19-34. ISBN 978-1-933864-42-6. NEOPLASIAS DO TRATO BILIAR; CANCER DE VESICULA BILIAR; FATOR DE CRESCIMENTO; FAMILIA ERBB; RECEPTOR DO FATOR DE CRESCIMENTO INSULIN-LIKE 1; C-MET; MTOR; COX-2 |
| 110/344 | US=8 / Laboratório Kunicki TJ, Nugent DJ. Human platelet antigens. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 2179-89. ISBN 978-0-443-06715-0. ANTIGENOS DE PLAQUETAS HUMANAS; GLICOPROTEINAS DA MEMBRANA DE PLAQUETAS; INTEGRINAS; RECEPTOR DE COESAO PLAQUETARIA; RECEPTOR DE COLAGENO DE PLAQUETAS; RECEPTOR DO COMPLEXO DA GLICOPROTEINA; GLICOLIPIDIOS DE PLAQUETAS; TROMBOCITOPENIA ALOIMUNE NEONATAL; PURPURA POS-TRANSFUSIONAL; GENETICA MOLECULAR; ISOANTIGENOS; ANTICORPOS; TROMBASTENIA DE GLANZMANN; SINDROME DE BERNARD-SOULIER; CITOCINAS |
| 111/344 | US=45 / Clín/Médica McCarty MF. Isoflavones made simple - agonist activity for the beta-type estrogen receptor may mediate their health benefits. In: Watson RR, editor. Complementary and alternative therapies in the agind population. Amsterdan: Elsevier, 2009. p. 475-522. ISBN 978-0-12-374228-5. ISOFLAVONAS; ATIVIDADE AGONISTA PARA O RECEPTOR DE ESTROGENIO BETA-TIPO; SOJA; ISOFLAVONAS; GENISTEINA; ERALPHA; ERBETA |
| 112/344 | US=45 / Gastro Boin IFSF, Leonardi MI, Leonardi LS. Transplantes hepáticos. In: Muraro CPM. Cirurgia do aparelho digestório. Rio de Janeiro: Rubio, 2009. p. 225-44. ISBN 85-7771-018-8. TRANSPLANTE HEPATICO. HISTORICO; CRITERIO MELD; AVALIACAO DO RECEPTOR; TRANSPLANTE HEPATICO. INDICACOES; TECNICA CIRURGICA; IMUNOSSUPRESSAO; RETRANSPLANTE |
| 113/344 | US=50 / Câncer Schoder H. Molecular imaging of cancer: receptors, angiogenesis, and gene expression. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 107-14. ISBN 978-1-60327-086-1. IMAGEM MOLECULAR DO CANCER; TOMOGRAFIA POR EMISSAO DE POSITRONS; CANCER; ANGIOGENESE; RECEPTOR DE IMAGEM |
| 114/344 | US=50 / Câncer Muller A, Homey B, Ferris RL. Head and neck cancer: an example for role of chemokine receptors in tumor progression and metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 243-54. ISBN 978-1-60327-086-1. CANCER DA CABECA E PESCOCO; RECEPTORES DE QUIMIOCINA EM PROGRESSAO TUMORAL; QUIMIOCINA; RECEPTOR DE QUIMIOCINA; CANCER DE CABECA E PESCOCO; INVASAO E METASTASE; CXCR4; CCR7 |
| 115/344 | US=50 / Câncer Karamouzis MV, Argiris A. Combined targeting of EGFR and angiogenesis in aerodigestive carcinomas. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 297-307. ISBN 978-1-60327-086-1. SEGMENTACAO COMBINADA DE EGFR; ANGIOGENESE NO CARCINOMA AERODIGESTIVO; CANCER DE PULMAO NAO PEQUENAS CELULAS; CANCER DE ESOFAGO; RECEPTOR DO FATOR EPITELIAL GROTH; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR |
| 116/344 | US=50 / Câncer Berz D, McCormack E, Mega A, Wanebo HJ. Targeting signaling pathways in cancer therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 309-26. ISBN 978-1-60327-086-1. EGFR; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; INIBIDORES DA QUINASE DE TIROSINA; MOLECULAS PEQUENAS; SOLIDAS MALIGNAS DE TUMORES; TERAPIA-ALVO; PREDITORES DE RESPOSTA; CANCER DE MAMA; CARCINOMA HEPATOCELULAR; CANCER DE PULMAO; CANCER DE COLON |
| 117/344 | US=50 / Câncer Baehner FL. Estrogen receptor-positive breast cancer: tradicional prognostics, molecular pathology: a new breast cancer taxonomy and 21st century personalized prognostic and predictive assays. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 465-95. ISBN 978-1-60327-086-1. PERFIL DE EXPRESSAO DE GENE; QRT-PCR; CANCER DE MAMA; CANCER DE MAMA TIPO BASAL; CANCER DA MAMA HER2 TIPO; CANCER DE MAMA TIPO LUMINAL; PROGNOSTICO; PREDITIVO |
| 118/344 | US=50 / Câncer Karrim J, Dubey S. Advances in the treatment of lung cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 545-52. ISBN 978-1-60327-086-1. TRATAMENTO DO CANCER DO PULMAO; NEOPLASIAS PULMONARES; QUIMIOTERAPIA; ADJUVANTE; MARCADORES BIOLOGICOS; ANGIOGENESE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DA PROTEINA QUINASE; ANTICORPOS MONOCLONAIS; RADIOTERAPIA |
| 119/344 | US=85 / Biol/Mol Sitorus RS, Gumay S, Valk PVD. The apoptotic paradox in retinoblastoma. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 77-93. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. PROLIFERACAO; APOPTOSE; INDICE MITOTICO; INDICE APOPTOTICO; MIB-1; CASPASE; CASPASE-3; RECEPTOR FAS; P53; RETINOBLASTOMA |
| 120/344 | US=89 / Biol/Mol Kang C, Pu P, Jiang H. Silencing epidermal growth factor receptor by RNA interference in glioma. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 335-49. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INTERFERENCIA DE RNA; GLIOMA; EGFR; INVASAO; PROLIFERACAO; SIRNA |